RGAx

RGAx serves as the innovation accelerator for Reinsurance Group of America (RGA), one of the world's largest life reinsurance companies. Established to drive transformation within the life, health, and annuities sectors, RGAx operates as a corporate venture arm, strategically investing in and partnering with early to growth-stage companies. Its primary objective is to identify and cultivate disruptive technologies and business models that can enhance the insurance value chain, from improving customer engagement and underwriting processes to streamlining claims and leveraging advanced data analytics.

The firm's investment strategy is highly focused on solutions that align with RGA's core business and long-term strategic goals. Rather than operating as a traditional venture capital fund with a fixed investment thesis, RGAx seeks out opportunities that offer mutual benefits, providing capital alongside RGA's extensive industry expertise, global network, and access to market. This approach allows RGAx to support its portfolio companies not just financially but also through strategic guidance and potential commercial partnerships, fostering innovation that can be integrated into the broader insurance ecosystem.

RGAx has demonstrated a consistent commitment to fostering innovation, having made investments in over 20 companies across various stages. While specific check sizes can vary based on the strategic fit and stage of the company, RGAx typically participates in funding rounds ranging from seed to Series B. For instance, they have been noted for their participation in a $10 million Series A round for a health data platform and a $12 million Series B round for an AI-powered underwriting solution. Their investments reflect a strategic interest in areas such as digital health, predictive analytics, personalized insurance products, and enhanced customer experiences, aiming to reshape the future of insurance.